Flecainide is classified as a class 1 antiarrhythmic drug which received USFDA approval in 1985 for the treatment of atrial…
Tag: affordable reimbursement scenario
Global Amdinocillin Market Is Expected To Grow At A CAGR Of 3.0% From 2020 To 2027 – Dagoretti Market Reports
Amdinocillin has broad-spectrum activity against infections caused due to gram-negative bacteria. The oral bioavailability of amdinocillin is very low hence…